Mingli Li

Company: KSQ Therapeutics

Job title: Associate Director - Process Development & Tech operation

Seminars:

Developing a Robust CRISPR-Cas9 Editing Process for a TIL Product 3:15 pm

Developing a robust gene editing process to retain cell health and function Optimization of editing process to precisely deliver CRISPER components to TILs, maintaining sterility throughout the editing process, and minimizing contamination rises Enhancing reproducibility, ensuring the safety and efficacy of the editing TIL productRead more

day: Conference Day Two